Vertex Pharmaceuticals Analyst Ratings
J&J Beats in Q4 With in Line Guidance; so Why Is Its Stock Falling?
Intra-Cellular Ticks Higher as J&J Forecasts Early Q2 Close
Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
Alnylam Pharmaceuticals Analyst Ratings
Top 4 Health Care Stocks You May Want To Dump In Q1
8 Health Care Stocks Whale Activity In Today's Session
Catalyst Watch: Netflix Earnings, Monster Beverage Event, Drug Data, and Quantum Volatility
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
McKesson, Vertex Pharmaceuticals Among Top Healthcare Quant Picks Before Q4 Earnings
How Is The Market Feeling About Vertex Pharmaceuticals?
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio With Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
Acadia Expects More Than $1B in Sales for 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Acadia Pharmaceuticals Key Milestones 2025-2026 Include DAYBUE Marketing Authorization Submitted To EMA; Managed Access In Europe Starts Q2 2025; COMPASS PWS Phase 3 and RADIANT Phase 2 Enrollment and Results Timeline; ACP-204 Lewy Body Dementia Study...
On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?
In 2025, the Biomedical mergers and acquisitions will begin.
Express News | U.S. stock night trading: Hong Kong and A-shares surged! Chinese concept stocks rose together, with Kingsoft Cloud up nearly 8%.
Futu Morning Report | Major new regulations impact AI Chip stocks! NVIDIA and Oracle strongly oppose; Is there a bet that the yield has peaked? Call Bid in U.S. Treasury ETF surges.
Media: NVIDIA's Blackwell chip rack has encountered issues, leading major customers like Microsoft to reduce some Orders; Trump's advisers have proposed a new tariff idea: use the Emergency Economic Powers Act to increase rates by 2-5% monthly; the new US Treasury Secretary's Hold Positions include the S&P 500, Nasdaq, and Bitcoin.
$1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today